A method for treating a condition selected from the group consisting of type 2 diabetes mellitus, obesity, NAFLD, nonalcoholic steatohepatitis, dyslipidemia, and metabolic syndrome, comprising administering to a patient in need thereof, an effective amount of a compound, or a pharmaceutically acceptable salt thereof, as claimed by 72
Vajdi M, Khorvash F, Rouhani MH, Ghavami A, Clark CCT, Askari G
This article demonstrates the efficacy of tirzepatide for treatment of MASH
Previous studies demonstrated that MTX administration provoked JAK1 and STAT3 phosphorylation in rat models of intestinal injury and hepatotoxicity using MTX (Hassanein et al
You can explore professional guidance through Healthcare.pro to determine whether this treatment aligns with your needs
GLP-1 medications are helping boost new categories for CPG giants, with those taking the injections looking for light, healthy meals to eat on a curbed appetite